集成显示和传递功能与细胞透模仿器作为细胞内多重定位的支架
Yugang Bai, Lien Nguyen, Ziyuan Song
1Laboratory of Drosophila Research and School of Life Sciences, The Chinese University of Hong Kong , Shatin, New Territories, Hong Kong SAR, China.
Journal of the American Chemical Society
|June 30, 2016
概括
针对有毒RNA重复的多价联体为I型肌性衰竭 (DM1) 提供了一种新的治疗策略. 这些化合物抑制RNA焦点和拼接缺陷,显示出治疗这种神经肌肉疾病的前景.
科学领域:
- 医学化学
- 分子生物学
- 神经科学
背景情况:
- 肌性缩 I型 (DM1) 是由扩大的CTG和CUG核酸重复引起的不可治愈的神经肌肉疾病.
- 针对这些有毒RNA重复是DM1药物开发的关键策略.
- 开发有效的细胞内治疗方法仍然是一个挑战.
研究的目的:
- 设计和合成针对扩展dCTG和rCUG重复的新型多价位联体结构.
- 评估这些配体在抑制核糖核聚焦形成和纠正拼接缺陷方面的有效性.
- 在DM1的细胞和体内模型中评估这些配体的治疗潜力.
主要方法:
- 使用细胞透 (CPP) 模拟为多价构造的支架.
- 对扩展CTG/CUG重复的结合因子和选择性进行了评估.
- 研究了 (CTG·CAG) 74重复体内转录的抑制.
- 在DM1模型细胞中评估了有毒CUGRNA的减少.
- 在DM1的Drosophila模型中测试了表型改善.
主要成果:
- 开发出有效结合扩展CTG和CUG重复的多价.
- 已证明低度抑制核结形成和扭转拼接缺陷.
- 显示了扩展重复体内转录的选择性抑制.
- 在DM1模型细胞中降低了毒性CUGRNA水平.
- 在DM1的Drosophila模型中观察到的表型改善.
结论:
- 在DM1中向有毒RNA重复时,多价联体策略是有效的.
- 这些配体通过抑制关键的病理机制来显示DM1的治疗潜力.
- 这种方法可能适用于其他三核酸重复性疾病和细胞内向策略.
相关概念视频
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
82
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
82
01:24Modified-Release Drug Delivery Systems: Site-Targeted
74
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
74
01:24Cellular Membranes and Drug Transport
2.0K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
2.0K
01:30Assembly of Signaling Complexes
7.0K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.0K